OncoZenge AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
October 31, 2023 at 01:00 pm IST
OncoZenge AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was SEK 4.19 million compared to SEK 3.21 million a year ago. Basic loss per share from continuing operations was SEK 0.36 compared to SEK 0.27 a year ago.
For the nine months, net loss was SEK 12.73 million compared to SEK 42.09 million a year ago. Basic loss per share from continuing operations was SEK 1.09 compared to SEK 3.59 a year ago.